Substantial Influenza Vaccine Effectiveness in Households with Children during the 2013-2014 Influenza Season, When 2009 Pandemic Influenza A(H1N1) Virus Predominated

Journal of Infectious Diseases

Volumn 213, Issue 8, 2016, Pages 1229-1236

  Ohmit, Suzanne E ^a   Petrie, Joshua G ^a   Malosh, Ryan E ^a   Johnson, Emileigh ^a   Truscon, Rachel ^a   Aaron, Barbara ^a   Martens, Casey ^a   Cheng, Caroline ^a   Fry, Alicia M ^b   Monto, Arnold S ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

households with children; influenza; serologic susceptibility; vaccine effectiveness

Indexed keywords

INFLUENZA VACCINE; SIALIDASE;

ACUTE RESPIRATORY TRACT DISEASE; ADOLESCENT; ANTIBODY TITER; ARTICLE; CHILD; COMMUNITY ACQUIRED INFECTION; DISEASE PREDISPOSITION; DRUG EFFICACY; ENZYME INHIBITION; FEMALE; HEMAGGLUTINATION INHIBITION; HUMAN; INFLUENZA A VIRUS (H1N1); MAJOR CLINICAL STUDY; MALE; PANDEMIC INFLUENZA; PRIORITY JOURNAL; SEROLOGY; TREATMENT RESPONSE; VACCINATION; ADULT; FAMILY SIZE; HEALTH SURVEY; IMMUNOLOGY; INFLUENZA, HUMAN; MIDDLE AGED; PRESCHOOL CHILD; STATISTICS AND NUMERICAL DATA; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FAMILY CHARACTERISTICS; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PUBLIC HEALTH SURVEILLANCE; VACCINATION; YOUNG ADULT;

EID: 84965141298     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv563     Document Type: Article

References (31)

1. Griffin MR, Monto AS, Belongia EA, et al. Effectiveness of non-adjuvanted pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 U.S. Communities. PLoS One 2011; 6:e23085.
2. Treanor J, Talbot HK, Ohmit SE, et al. Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains. Clin Infect Dis 2012; 55:951-9.
3. Ohmit SE, Thompson MG, Petrie JG, et al. Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis 2014; 58:319-27.
4. McLean HQ, Thompson MG, Sundaram ME, et al. Influenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus type. J Infect Dis 2015; 211:1529-40.
5. Foppa IM, Haber M, Ferdinands JM, et al. the case test-negative design for studies of the effectiveness of influenza vaccine. Vaccine 2013; 31:3104-9.
6. Jackson ML, Nelson JC. the test-negative design for estimating influenza vaccine effectiveness. Vaccine 2013; 19:2165-8.
7. Jackson ML, Rothman KJ. Effects of imperfect test sensitivity and specificity on observational studies of influenza vaccine effectiveness. Vaccine 2015; 33:1313-6.
8. Osterholm MT, Kelley NS, Sommer A, Belongia A. Efficacy and effectiveness of influenza vaccines: A systematic review and meta-analysis. Lancet Infect Dis 2012; 12:36-44.
9. Ohmit SE, Petrie JG, Malosh RE, et al. Influenza vaccine effectiveness in the community and the household. Clin Infect Dis 2013; 56:1363-9.
10. Ohmit SE, Petrie JG, Malosh RE, Fry AM, Thompson MG, Monto AS. Influenza vaccine effectiveness in households with children during the 2012-2013 season: assessments of prior vaccination and serologic susceptibility. J Infect Dis 2015; 211:1519-28.
11. Monto AS, Malosh RE, Petrie JG, Thompson MG, Ohmit SE. Frequency of acute respiratory illnesses and circulation of respiratory viruses in households with children over 3 surveillance seasons. J Infect Dis 2014; 210:1792-9.
12. Petrie JG, Ohmit SE, Cowling BJ, et al. Influenza transmission in a cohort of households with children: 2010-2011. PLoS One 2013; 8:e75339.
13. Epperson S, Blanton L, Kniss K, et al. Influenza activity-United States, 2013-14 season and composition of the 2014-15 influenza vaccines. MMWR Morb Mortal Wkly Rep 2014; 63:483-90.
14. Appiah GD, Blanton L, D'Mello T, et al. Influenza activity-United States, 2014-15 season and composition of the 2015-16 influenza vaccine. MMWR Morb Mortal Wkly Rep 2015; 64:583-90.
15. Ohmit SE, Petrie JG, Cross RT, Johnson E, Monto AS. Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection. J Infect Dis 2011; 204:1879-85.
16. Monto AS, Petrie JG, Cross RT, et al. Antibody to influenza virus neuraminidase: an independent correlate of protection. J Infect Dis 2015; 212:1191-9.
17. Grohskopf LA, Shay DK, Shimabukuro TT, et al. Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP)-United States, 2013-2014. MMWR Recomm Rep 2013; 62(RR-07):1-43.
18. Wei LJ, Lin DY,Weissfield L. Regression analysis of multivariate incomplete failure time data by modeling marginal distribution. J Am Statistical Assoc 1989; 84:1065-73.
19. Flannery B, Thaker SN, Clippard J, et al. Interim estimates of 2013-2014 seasonal influenza vaccine effectiveness-United States, February 2014. MMWR Morb Mortal Wkly Rep 2014; 63:137-42.
20. Valenciano M, Kissling E, Reuss A, et al. the European I-Move multicentre 2013-2014 case-control study. Homogeneous moderate influenza vaccine effectiveness against A (H1N1) pdm09 and heterogeneous results by country against A (H3N2). Vaccine 2015; 33:2813-22.
21. Belshe RB, Edwards KM, Vesikari T, et al. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med 2007; 356:685-96.
22. Grohskopf LA, Olsen SJ, Sokolow LZ, et al. Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2014. MMWR Morb Mortal Wkly Rep 2014; 63:691-7.
23. Centers for Disease Control and Prevention. Advisory Committee on Immunization Practices (ACIP) reaffirms recommendation for annual influenza vaccination: no stated preference for nasal spray vaccine or flu shot expressed. http://www.cdc. gov/media/releases/2015/s0226-acip.html. Accessed 17 August 2015.
24. Russell CA, Jones TC, Barr IC, et al. Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza vaccines. Vaccine 2008; 26 (suppl 4):D31-4.
25. Fonville JM, Wilks SH, James SL, et al. Antibody landscapes after influenza virus infection or vaccination. Science 2014; 346:996-1000.
26. Bedford T, Riley S, Barr IG, et al. Global circulation patterns of seasonal influenza viruses vary with antigenic drift. Nature 2015; 523:217-20.
27. Truscott J, Fraser C, Cauchemez S, et al. Essential epidemiological mechanisms underpinning the transmission dynamics of seasonal influenza. J Royal Society Interface 2012; 9:304-12.
28. Thompson WW, Weintraub E, Dhankhar P, et al. Estimates of US influenzaassociated deaths made using four different methods. Influenza Other Respir Viruses 2009; 3:37-49.
29. Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United States. JAMA 2004; 292:1333-40.
30. Hayward AC, Fragaszy EB, Bermingham A, et al. Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch Cohort study. Lancet Respir Med 2014; 2:445-54.
31. Smith DJ, Lapedes AS, de Jong JC, et al. Mapping the antigenic and genetic evolution of influenza viruses. Science 2004; 305:371-6.